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Enhanced Contribution of HLA in Pediatric Onset Ulcerative Colitis
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Background: The genetic contributions to pediatric onset ulcerative colitis (UC), characterized by severe disease and extensive colonic involvement, are largely unknown. In adult onset UC, Genome Wide Association Study (GWAS) has identified numerous loci, most of which have a
modest susceptibility risk (OR 0.84–1.14), with the exception of the human leukocyte antigen (HLA) region on Chromosome 6 (OR 3.59).
Method: To study the genetic contribution to exclusive pediatric onset UC, a GWAS was performed on 466 cases with 2099 healthy controls

using UK Biobank array. SNP2HLA was used to impute classical HLA alleles and their corresponding amino acids, and the results are compared
with adult onset UC.

Results: HLA explained the almost entire association signal, dominated with 191 single nucleotide polymorphisms (SNPs) (p = 5 x 10-8 to 5 x

10-10). Although very small effects, established SNPs in adult onset UC loci had similar direction and magnitude in pediatric onset UC. SNP2HLA
imputation identified HLA-DRB1*0103 (odds ratio [OR] = 6.941, p = 1.92*10–13) as the most significant association for pediatric UC compared
with adult onset UC (OR = 3.59). Further conditioning showed independent effects for HLA-DRB1*1301 (OR = 2.25, p = 7.92*10–9) and
another SNP rs17188113 (OR = 0.48, p = 7.56*10–9). Two HLA-DRB1 causal alleles are shared with adult onset UC, while at least 2 signals
are unique to pediatric UC. Subsequent stratified analyses indicated that HLA-DRB1*0103 has stronger association for extensive disease (E4:
OR = 8.28, p = 4.66x10-10) and female gender (OR = 8.85, p = 4.82x10-13).

Conclusion: In pediatric onset UC, the HLA explains almost the entire genetic associations. In addition, the HLA association is approximately
twice as strong in pediatric UC compared with adults, due to a combination of novel and shared effects. We speculate the paramount importance
of antigenic stimulation either by infectious or noninfectious stimuli as a causal event in pediatric UC onset.
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INTRODUCTION
Ulcerative Colitis (UC) is 1 of the 2 main forms of chronic
inflammatory bowel disease (IBD) with a wide age range or disease onset which varies from infancy to late adulthood.1, 2 The
clinical, endoscopic, and histologic features are generally similar
across the age spectrum. Numerous genome-wide association
studies (GWAS) and subsequent meta-analyses in IBD have
confirmed the heritability of UC by uncovering many genetic
susceptibility loci.3, 4 To date, more than 200 loci are implicated
in IBD, with 29 loci being UC specific.5 While GWAS has uncovered new and unsuspected pathways for pathogenesis, each locus
only has very small to modest effect size,5–7 with the exception
of a strong association for human leukocyte antigen (HLA) loci
on chromosome 67 that consistently shows a large effect on UC
susceptibility. Despite advances in understanding the etiology
of UC, 2 major questions remain unanswered: do genetic factors contribute differentially to pediatric versus adult onset, and
why do some patients have limited distal disease while others
have extensive disease or pancolitis? It is observed that pediatric onset UC is characterized by extensive colonic involvement
(80% pancolitis in children compared to only 30–40%8, 9 in adult
onset) and younger age of onset.10 This observation suggests
that genetic effects may be higher in children and, hence, that
dissection of UC genetic effects in pediatric cases may identify
additional susceptibility genes and further address the unanswered questions in UC. However, 2 previous GWA studies11,
12
in pediatric IBD where UC was included as a sub-phenotype
neither identified new loci exclusive to younger onset nor shed
any new information on the HLA region pertaining to pediatric
onset, most likely due to lack of power.
The HLA complex contains highly polymorphic human
leukocyte antigen genes and various other immune-regulatory
genes.13 HLA polymorphisms were the focus of attention in several modestly sized IBD studies involving mainly adult onset
UC. These studies have indicated that multiple independent
associations are likely to exist in HLA and non-HLA regions,
with consistent associations observed at class-II loci, mainly
HLA-DRB1 and HLADQB16, 7, 14. A recent study involving
HLA proteins in seropositive rheumatoid arthritis, another
inflammatory disorder, was able to narrow down most of the
association from 3 HLA proteins to 5 amino acids.15 Therefore,
to further define genetic associations across the HLA region and
identify functional and potentially causal single nucleotide polymorphisms (SNPs) in UC, we report here the performance of
a GWAS in a well-phenotyped pediatric UC cohort using a fine
mapping chip with excellent coverage across the extended HLA
region. We recruited an exclusively pediatric onset cohort of 768
de novo cases and used the Affymetrix UK Biobank Array, a
high-density custom array designed for fine mapping. Our aim
was to determine how the allele architecture of pediatric UC
compares to that of adult onset UC particularly focusing on the
HLA region. We also tested to see if any of the same causal variant(s) are driving the association between pediatric and adult
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onset UC using the Bayesian coloc package.16 We report novel
findings pertaining to HLA signals in pediatric UC, including
a doubling of HLA effects in pediatric compared to adult onset
and larger effect in female gender. Furthermore, the detected signals in HLA region can be explained by 2 classical HLA-DRB1
alleles (shared with adult onset UC) and 2 other independent
signals (may be unique to the pediatric onset UC).

METHODS
Patient Population
A total of 768 children between the ages 4 and 17 (mean age
12.7, female 49%) with the diagnosis of UC were recruited into the
study. Standard criteria were used to establish a diagnosis of UC.17–
19
All the patients were newly diagnosed children and adolescents
with ulcerative colitis treated with consensus defined treatment
regimens of mesalamine and corticosteroids (CS) after established
uniform pretherapy criteria. Twenty-nine North American centers
participated to recruit the study patients. Comprehensive demographic, clinical, laboratory, and serologic values were obtained
along with whole genome genotypes and diagnostic ileocolonoscopy and esophagogastroduodenoscopy. Disease extent was based
on visual appearance of colonic mucosa, not biopsy, and classified as proctosigmoiditis, left-sided disease (to the splenic flexure),
extensive disease (to the hepatic flexure), and pancolitis (beyond
the hepatic flexure). Biopsy specimens were only used for patients
who met all study criteria at the time of diagnosis.

Genotyping
Whole blood from 768 newly diagnosed pediatric UC
patients was stored at -80ºC until DNA was extracted using
standard protocols on a Thermo Scientific King Fisher Flex
system at Akesogen Inc (Norcross, GA). DNA was quantified via spectrophotometer and suspended at a concentration
of 50ng/uL. Genome-wide genotyping of the DNA was done
using the Affymetrix UK Biobank Axiom Array at Akesogen
Inc. The UK biobank array is a high-density custom designed
array with 7,348 SNPs across the HLA region (~24,000
high-quality imputed SNPs) and over 830,115 established
SNPs across the genome (~4 million high-quality imputed
SNPs). The UK Biobank Axiom Array covers a wide range of
rare coding SNPs, pharmacogenomics markers, copy number
regions, HLA, inflammation, and expression quantitative trait
loci (eQTL) SNPs. It was recently used in a study to identify
independent associations for prognosis relative to susceptibility in Crohn’s disease.20 In our study, the genotypes of ~27,000
disease-free ethnicity-matched healthy controls were obtained
from the UK Biobank consortium.

Quality Control and Statistical Analysis
Raw genotype image files (.CEL) from cases and controls
were analyzed. For each pediatric UC case, 5 closely related
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UK Biobank controls (total of 3840 controls) were selected by
matching their genetic distribution in principal component analysis (PCA). Cases and controls were processed as 1 batch, and
genotypes were called using Axiom Analysis Suite provided by
Affymetrix (Affymetrix, Inc., Santa Clara, CA). Further, the
samples were tested for data completeness, and those with SNP
call rates <95% were excluded. Samples that remained were
tested for agreement between X/Y genotypes and reported sex
and for unexpected relatedness between individuals by applying
RELPAIR and GRR1421 to ~20,000 markers in linkage equilibrium (pairwise r2<0.1 evenly distributed across the genome).
Samples with discordant gender were excluded from analyses.
For pairs of individuals that appeared to be genetically related,
1 of the pair was removed from subsequent analyses. One member from all first- and second-degree relative pairs (r >= 0.25)
was dropped. Overall, approximately 5% of the samples were
excluded for these reasons.
Additionally, a filtering criteria was applied to 776,463
autosomal SNPs to exclude those with genotyping call rate <0.95
and Hardy-Weinberg equilibrium P < 1 x 10-7. Approximately
5% of the SNPs were dropped during this process.
After excluding the unqualified samples and SNPs in
the preimputation process, our final dataset included 734
cases, 3651 controls, and 746,272 autosomal SNPs. To investigate population structure and identify population outliers,
we used principal components analysis (PCA). Starting with
the high-quality filtered SNPs, a subset of ~20,000 SNPs with
moderate minor allele frequency and no linkage disequilibrium
(LD) (r2 < 0.1) were selected. The principal components (PCs)
were inferred for all samples of each phase of the cohort using
PCA analysis in plink.22 Samples were plotted in PC space,
and outliers that exceeded cut-off thresholds were dropped
(Supplementary Fig. 1). After removing the outliers, a dataset
of only European-ancestry samples (466 cases and 2099 controls) was selected. The observed genomic control value 1.07
indicates little evidence of population stratification after controlling for global ancestries. This suggests that there was little
or no inflation leading to false positives from confounding by
ancestry. All the statistical QC processing and analysis were
done using plink1.09.23

Imputation-based Association Analysis,
Meta-analysis
IMPUTE2,24 a genotype imputation method, was applied
to impute the European ancestry dataset to the 1000 Genomes
Project Phase 3 integrated autosomal reference panel. The
imputed SNPs with minor allele frequency (MAF) <0.05 and
imputation quality scores <0.95 were excluded. Therefore, this
pediatric UC GWAS analysis was narrowed down to only common SNPs. The imputation yielded ~4 million high-quality
SNPs across the entire genome after excluding INDELs and
copy number variants (CNVs). Genotype imputation clouds

Novel PPARγ Agonist Decreases Inflammation in Colitis

(ie, the full genotype probability values, not single point estimates) from IMPUTE2 were directly used to assess association
using SNPTEST 2.5.225 under an additive model (-frequentist
1, -method score parameter options). An association p-value of
<5 x 10-8 (corresponding to a genome-wide significance level of
0.05 after a Bonferroni correction for multiple testing of 1million SNPs) was considered statistically significant.

Imputing HLA Genotypes
SNP2HLA26 was used to perform imputation of classical
HLA alleles and their corresponding amino acids from SNP
genotyping data. The Type 1 Diabetes Genetics Consortium
(T1DGC) dataset of 5225 unrelated individuals of European
ancestry is the major reference panel for SNP2HLA, which contains genotypes for 8961 HLA SNPs and amino acids covering
the entire HLA region including the classical alleles HLA- A, B,
C, DRB1, DQA1, DQB1, DPA1, and DPB1 at two- and fourdigit resolution. The accuracy of SNP2HLA program for the
T1DGC reference panel has been very well documented using a
different dataset.27 Our final GWAS dataset (before IMPUTE2
imputation) was tested against the T1DGC, and only the SNPs
in the HLA region were imputed. Association was tested across
the HLA by applying a logistic regression framework using
plink1.09.23

Conditional Analysis
Given that the classical HLA-DRB1 allele had the most
significant association signal in pediatric UC, we examined
whether there were any other independent effects by applying
the same logistic regression stated in the previous section to test
the remaining markers across the HLA region conditioned on
the HLA-DRB1 genotype. If any SNPs were identified as an
independent association, we used their covariates to condition
in subsequent analyses. Subsequent conditional analyses were
performed until no marker with significant independent association at P < 5 x 10-8 emerged.

Colocalization of Signals in Pediatric and
Adult UC
We performed colocalization to identify if the causal variants driving the association in 2 different traits (here pediatric onset and adult onset UC are considered different traits)
are the same or different, using the coloc package.16 Published
literature7 from adult onset UC GWAS has identified HLADRB1*0103 and rs6927022 as the 2 most important alleles
driving the signals across the HLA class II region. Since neither
rs6927022 nor any proxy SNPs with r2 > 0.5 were present in
the imputed SNP dataset, that site could not be evaluated for
sharing. Coloc uses a Bayesian framework to generate posterior probabilities for 5 mutually exclusive hypotheses regarding
the sharing of causal variants between 2 traits, namely H0 (no
causal variant for either trait); H1 or H2 (a causal variant only
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for 1 or the other trait); H3 (there are 2 distinct causal variants,
1 for each trait); and H4 (a single causal variant common to
both traits). We directly used the SNP-level association results
and performed coloc analyses at each of the 6742 variants
across the HLA, which are common in both traits, using 50kb
windows around each target SNP. The analysis was repeated
after conditioning on the pediatric associations, but because
only summary p-values were available for the adult cases, the
reciprocal conditional analysis could not be performed.

RESULTS
We first performed a genome-wide association study to
identify any novel associations and to replicate loci reported
from previous UC-centered GWAS. Additionally, the extended
HLA region was imputed against the T1DGC reference panel
to find HLA SNPs, classical HLA alleles, and their corresponding amino acids associated with pediatric UC. The analysis
workflow is described in Fig. 1.
The Manhattan plot (Fig. 2A) shows the association signals for 3,996,700 SNPs that passed pre- and postimputation
QC procedures. The p-value cut-off of P < 5 x 10-8 was used
to identify any genome-wide significant associations. Our study
identified 191 SNPs as genome-wide significant (Supplementary
Table 1). The locus plot across the HLA region (Supplementary
Fig. 2) exhibits not only 191 genome-wide significant SNPs,
but hundreds of other associated SNPs all in linkage disequilibrium (LD) with the strong associations. The Q-Q plots with
and without the HLA SNPs show significant departure from
the null hypothesis driven by HLA (Fig. 2B), which is almost
eliminated when the HLA region is removed (Fig. 2C).

Replication of Existing Results
We compared our GWAS results against the recently published meta-analyses in IBD.5 After a stringent quality control
process, our study produced genotypes for 183 of the 232 SNPs
reported as known to be associated with CD, IBD, and/or UC
in Europeans.5 Of the 73 known UC significant loci5 (P < 5 x
10-8 in adult UC) tested, 24 were replicated at P < 0.05 in our
pediatric onset UC cohort (Supplementary Table 2). The estimated effects of 73 common risk SNPs discovered in primarily
adult onset UC cohorts had very similar magnitudes and directions in our pediatric UC onset cohort (Supplementary Fig. 3)
with just 8 inconsistent signs for small effect loci. Similarly,
we replicated 9 out of 11 SNPs found in the adult onset UC
GWAS dataset.27 This suggests that the allelic contributions to
adult and pediatric onset UC are very similar, as far as common
SNPs with minor allele frequency (MAF) >5% are concerned.

Search for Associations Across the HLA Region
Because 191 SNPs in the HLA region exhibited multi-test
corrected genome-wide significance (Fig. 3), the HLA region
was subjected to a specific detailed analysis. The SNPs across
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the HLA region which passed QC were used as the backbone to
impute against the T1DGC reference panel using the SNP2HLA
package. This technique collapsed many of the highly redundant SNPs into haplotypes and classical HLA alleles. The final
HLA dataset after imputation contained a total of the 8115
HLA alleles, SNPs, and amino acid variants which were tested
for association, including 79 of 126 classical HLA alleles at
two-digit resolution, 102 of 298 classical HLA alleles at fourdigit resolution, and 991 of 1276 polymorphic amino acids.
This analysis wrapped our initial 191 highly associated SNPs
into 16 independent SNPs and HLA alleles with genome-wide
significance. By far the most highly associated allele was HLADRB1*0103, with an odds ratio (OR) of 6.94 (95% confidence
interval [CI] 6.42–7.47) and p = 1.92*10–13. Notably, HLADRB1*0103 was also reported in Goyette et al.,7 an adult onset
UC study, as the most significant allele with an OR of 3.59 (CI
3.22–4.00), which is about half of the effect size we observed
in our pediatric onset UC cohort. We compared our pediatric
UC OR with adult UC OR for 56 classical HLA alleles, which
are shown as significant with P < 5 x 10-8 in adult UC (Fig. 4),
finding no more than 6 loci with possible differences in effect
sizes and a few instances of inverted sign.

Conditioning Effect on HLA Amino Acid Variants
We also noticed the effect of HLA-DRB1*0103 conditional analysis on the associations observed at specific amino
acids. Of all the amino acids tested in HLA-DRB1*0103, there
are 2 strong amino acid associations mapped to position at 71.
These amino acids are Glu71 (OR = 1.969 and p = 1.24 × 1010
) and Lys71 or Arg71 (OR = 1.724 and p = 1.83 × 10-9)
(Supplementary Fig. 4A). Conditioning on HLA-DRB1*0103
completely suppressed the 2 strongest amino acid associations,
and none of the additional associations were shown as significant (Supplementary Fig. 4B).

Search for Additional HLA Signals
Because the association to HLA-DRB1*0103 is extremely
strong (OR of 6.94), highly replicated in adults, and resides in a
region with extensive LD, we next asked whether there were any
additional independent signals in the HLA region. To test this,
we repeated the logistic regression, treating HLA-DRB1*0103 as
a co-variate and, thus, removing its effect. After this procedure,
31 SNPs remained genome-wide significant. Among the 31 SNPs,
HLA-DRB1*1301 had the strongest OR of 2.25 (CI 1.97–2.5) and
p = 7.92*10-9, which is also significant in the univariate test, and
thus we selected it for a second round of conditioning. Now using
both HLA-DRB1*0103 and HLA-DRB1*1301 as covariates, 23
SNPs remained as genome-wide significant, with SNP rs17188113
having OR = 0.48 and p = 7.56*10-9. The third round of conditioning included HLA-DRB1*0103, HLA-DRB1*1301, and
rs17188113 as covariates, and no additional SNPs further emerged
as genome-wide significant. From this series of conditioning, our
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FIGURE 1. Experiment design flowchart for the entire analysis. An independent GWAS was performed on 466 pediatric UC cases/ 2099 UK Biobank
controls (GWAS genotyped on UK Biobank array). After QC and imputation based association analysis with IMPUTE2, the SNPs across the HLA region
was imputed using SNP2HLA and tested for any HLA association for pediatric UC.

analysis concludes that HLA-DRB1*0103, HLA-DRB1*1301,
and rs17188113 appear to capture all the independent genomewide significant signals in the HLA region of our pediatric onset
UC cohort. The univariate and conditional effects of all other
SNPs across the HLA region for our entire pediatric UC dataset
are given in Figs. 5A-5B and Supplementary Table 3.

HLA Signals Between Pediatric Versus Adult
Onset UC
We next performed colocalization analysis,16 testing the
hypothesis that HLA associations in our pediatric dataset directly correspond to the same alleles as observed in the adult
UC GWAS study.7 The Bayesian algorithm in coloc generates
posterior probabilities for the hypotheses that the associations at a locus are different in the 2 datasets (H3) or due to
the same SNP or credible interval (H4). These are plotted in
Fig. 5C, which indicates that there appear to be 4 associations,
2 each (1 shared and 1 separate) in the Class 1 (HLA- A, B and
C) and class II (HLA- DP, DM, DOA, DOB, DQ, and DR)
intervals. The HLA-DR locus at MB 32.3 to 32.7 shows very
high posterior probabilities for a pediatric-specific haplotype,

which is centered on rs17495592 in the vicinity of HLA-DRB5
(H3: blue SNPs), and a shared haplotype, which corresponds
to HLA-DRB1 (H4: yellow SNPs). Conditioned on HLADRB1*0103, the H4 signal dominates the locus (Fig. 5D) and
is likely due to HLA-DRB1*1301, although some residual secondary H4 signal is retained when we also further condition
on HLA-DRB1*1301 (Fig. 5E). Alternatively, the complex LD
structure at the locus may confound the analysis leading to false
posterior probability estimates: there is clearly LD between
rs17495592 and HLA-DRB1 and independently conditioning
on rs17495592 reduces both the association signal and the posterior probabilities at the HLA-DRB1 locus (data not shown).
We were unable to perform reciprocal conditioning on the adult
HLA associations since only summary p-values are available,
and note that rs6927022, identified as the second peak in the
adult HLA,7 was not present in our imputed genotypes.
Similarly, at the HLA class I locus (position at 30.5-30.6
MB), an independent strong nonshared signal (H3) was seen due
to rs17188113. This signal is unambiguously driven by pediatric
onset UC because rs17188113 was seen with significant association in our dataset but not in the adult UC. In addition, there
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FIGURE 2. (A) Manhattan plot of SNP association p-values result for Pediatric UC cases vs UKB controls for 3,996,700 SNPs qualified after pre- and
postimputation QC procedures. All SNPs are plotted according to their position on each chromosome on x-axis, against their association on y-axis.
The red and blue lines indicate the genome-wide significance (p ≤ 5x10-8) and the suggestive significance threshold (p ≤ 1x10-5), respectively.
Genome-wide significant signals are labeled with corresponding gene names. The inset QQ plots shows the observed (y-axis) against the expected
(x-axis) distribution of p-values under the null hypothesis with (B) and without HLA region (C).

appears to be some evidence for a shared H4 association further
conditioned on this SNP, at MB 30.7 (Fig. 5F), although it fails
to drop below P < 0.005 in association modeling.

Search for Gender and Sub-phenotype
Associations
A recent Juvenile Idiopathic Arthritis (JIA) study
reported that the SNP rs2476601 association in the PTPN22
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gene is restricted to females and is not observed in males.28 We,
therefore, attempted to generate further evidences for male (239
cases) or female (227 cases) specific/consistent association of
classical HLA alleles in our pediatric UC cohort. Somewhat
surprisingly, our major allele HLA-DRB1*0103 seems to have
a significantly stronger effect in females (p = 4.82x10-13 and
OR = 8.85 [CI 8.2–9.5]) than in males (p = 1.53 x 10-5 and OR 4.84
[CI 4.1–5.5]). Conditioning on HLA-DRB1*0103 in males and
females seemed to reverse this pattern, although less strikingly
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FIGURE 3. LocusZoom plots of SNPs around HLA-II positions (32.2MB to 32.8MB) on chromosome6 against –log10 p-value for their genetic associations from IMPUTE2. The top SNP is highlighted in purple. The surrounding SNPs, shown within 500kb of the top SNP are color coded to reflect their
linkage disequilibrium in r2 with the top SNP. Estimated recombination rates are plotted in pale blue to reflect local LD structure on secondary y-axis.

with males having an OR of 2.70 (CI 2.35–3.04) and females
1.6911 (CI 1.29–3.0) for HLA-DRB1*1301. Lastly, conditioning on both HLA-DRB1*0103 and HLA-DRB1*1301 in males
and females showed that ORs of 0.44 (CI 0.34–0.71) and 0.53
(CI 0.19–0.86), respectively for rs17188113. Overall, it appears
that HLA-DRB1*0103 has a significantly stronger apparent effect in females, HLA-DRB1*1301 seems to be slightly
more associated in males, and rs17188113 has an equal effect
in both. The conditioning effect of all other SNPs across the
HLA region for males and females are given in Supplementary

Tables 4 and 5 and Supplementary Figures 5 and 6, respectively.
Finally, we performed an association analysis for sub-phenotypes such as “extensive disease” (E4), because previous reports
have indicated the higher effect of HLA on pancolitis phenotype in adult UC. The OR has increased to 8.28 (CI 7.6–9.0)
with E4 pediatric UC, and the OR increased to 9.4 (CI 8.6–10.3)
when the analysis was restricted to females with E4 (Table 1).
The conditioning effect of the remaining SNPs across the HLA
region for E4 in pediatric UC and females with E4 are given in
Supplementary Tables 6 and 7, respectively. We also tested if

FIGURE 4. Comparison of pediatric and adult UC odds ratios for 56 classical HLA alleles which are considered as significant with P < 5 x 10-8 in adult
UC cohort. OR values for pediatric and adult UC are red and blue, respectively.
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FIGURE 5. Association tests across the HLA region in our pediatric onset UC dataset (466 Cases and 2099 Controls). (A) The major genetic determinants of UC risk map to HLA-DRB1 (OR = 6.94; p = 1.92*10-13). Un-conditional association analysis results for 79 two-digit (red), 102 four-digit HLA
alleles (green), 741 single–amino acid variants (blue) and 5,568 other SNPs across the HLA region. (B) Subsequent conditional analyses on HLADRB1*0103 controlling all other high LD alleles revealed an independent association to HLA-DRB1*1301 (OR = 2.25; p = 7.92*10-9). Results obtained
for this dataset is given in Supplementary Table 3. (C-F) Tests of colocalization of causal variants across the HLA region between pediatric and adult
onset UC showing posterior probabilities computed by coloc at each SNP for H3 (distinct nonshared causal variants, blue circles) and H4 (shared
causal variant, yellow points) (C) The coloc comparison between pediatric versus adult onset UC on univariate p-values from the pediatric and adult
studies. (D) The coloc comparison between pediatric onset UC (after first conditioning on HLA-DRB1*0103) with adult onset UC univariate results.
(E) The coloc comparison between pediatric onset UC (after additionally conditioning on HLA-DRB1*1301) with adult onset UC univariate results. (F)
The coloc comparison between pediatric onset UC (after thirdly conditioning additionally on rs17188113) with adult onset UC univariate results.

the younger age of onset (dichotomized to under 12 versus over
12 years) among the pediatric UC and did not see increasing
association with younger onset.

DISCUSSION
Ulcerative colitis is characterized by chronic mucosal
inflammation limited to the colon with histo-pathological features that are strikingly similar, regardless of age of onset.29
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However, pediatric onset UC (onset of less than 17 years of
age) differs from adult IBD in that 75–80% of children present
with pancolonic distribution, compared with about 30–40% in
adult UC.9, 30 This difference, in part, may explain why pediatric
onset UC is also characterized by a high need for corticosteroid therapy, frequent medically refractory disease, and a high
rate of treatment failure, which leads to higher risk for colectomy compared to adult UC.31 Surprisingly, neither disease
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TABLE 1: Association of HLA-DRB1*0103 in Different
Phenotypes of Our Pediatric UC Cohort
Phenotypes
Pediatric UC - entire dataset
Males only
Females only
Extensive (E4) disease only
Females + E4

Odd ratio (95% CI)

p

6.94 (6.4–7.5)
4.84 (4.1–5.6)
8.85 (8.2–9.5)
8.28 (7.6–9.0)
9.46 (8.6–10.3)

1.92E-13
1.53E-05
4.82E-13
4.66E-10
1.18E-07

distribution nor the age of onset differences in UC have been
explained by the advances attributed to GWAS studies, despite
the inclusion of pediatric UC as a sub-phenotype.32 Common
susceptibility SNPs in UC show similar allele architectures in
pediatric and adult onset UC including the dominance of the
HLA region. In this study, we have performed a GWAS narrowed to pediatric UC cases only, with the objective to identify
any novel associations, to refine existing associations, and to
better explore the role of HLA in early onset UC.
Comparing our results against the recently published
meta-analyses in IBD,5 we were able to replicate 24 of the 73
known UC SNPs at P < 0.05. Low power in a sample of 466
cases is the most likely explanation for the lack of replication
of the remaining 49 SNPs, since the estimated effects of all the
Liu et. al.5 had very similar magnitudes and directions in our
pediatric cohort.
The most intriguing results from our study are the findings pertaining to the HLA region in pediatric onset UC. Not
only did the locus plot across the HLA region indicate 191
genome-wide significant SNPs, but it also showed hundreds of
more weakly associated SNPs all in LD with the strong associations. The Q-Q plots with and without HLA showed that
the genetic signal was almost entirely eliminated when the
HLA region was removed, confirming that genetic susceptibility of pediatric onset UC is predominately explained and
driven by HLA SNPs. This observation has been observed in
numerous studies before.8, 33 Because the HLA region merited
specific detailed analysis to determine if functional and causal
SNPs can be identified, we proceeded with imputing our dataset against the T1DGC reference panel using the SNP2HLA
package. This process collapsed many of the highly redundant
SNPs into haplotypes and classical HLA alleles. The most associated allele in our study was HLA-DRB1*0103, with an odds
ratio of nearly 7 (OR = 6.941; p = 1.92*10-13). The same allele
was reported in an adult onset UC study as the most significant
variant with an odds ratio of only 3.59, which is about half of
what we observed in our pediatric onset UC. The coloc analysis
suggests that the signal at HLA-DRB1*0103 may be due to
different main effect alleles in the pediatric and adult samples,
possibly with a secondary shared effect in high LD. A shared
association at nearby HLA-DRB1*1301 also appears to have
a considerably larger effect in the pediatric cases. Conditional

analysis also revealed a third pediatric-specific signal centered
on rs17188113, and together, these 3 alleles appear to explain
most of the signals within the HLA region in our dataset.
Finally, we have performed association analysis for
sub-phenotypes such as gender and extensive disease, as much
as previous reports indicated the higher effect of HLA on pancolitis phenotype in adult UC. Although pediatric UC is not
a gender biased disorder,34 our finding of higher HLA risk to
more of the female gender warrants further investigation. The
HLA risk in our study also increased with “extensive disease”
(E4) in pediatric UC, and increased further when the analysis
was restricted to females with extensive disease. Because conditional analysis used here is based generally on the assumption
that single primary association signals allow conditioning on a
relatively homogeneous set of cases and controls that exhibit
this association, additional layers of complexity can exist.
Nevertheless, our data clearly suggests that in contrast to a
single locus model, the strong HLA associations with younger
onset and gender results from complex, multi-locus effects that
span the entire HLA region. Population studies reveal HLA
class I and class II gene polymorphisms associated with almost
all the common chronic autoimmune diseases, notably spondylarthropathies, rheumatoid arthritis, multiple sclerosis, and
type I diabetes. Despite no known reliably measurable auto-antibodies in UC, the stronger association of HLA in early onset
UC suggests a role for auto-immunity in pediatric onset UC.
In summary, we performed a genome-wide association
and fine mapping study in a narrow phenotype of pediatric UC
patients using 2 well characterized cohorts. Although underpowered to detect small effects of disease associations, this is the first
such study using exclusively pediatric onset UC cases. The HLA
explained the almost entire association signal, dominated with
191 SNPs in high LD. The first being that the HLA-DRB1*0103
contribution is almost twice as high in pediatric UC when compared to adult onset UC. Several other HLA alleles for UC
also have a higher OR in children than in adults. The coloc
results further suggest that primary associations in both the
class I and class II regions involve pediatric-specific effects, but
that the 2 HLA DRB1 alleles are shared since they associate in
both pediatric and adult cohorts. The larger effect size of HLA
DRB1*0103 in children may in part be due to some signal from
the pediatric-specific peak near the locus, but is mainly intrinsic
to the haplotype. Based on these findings we propose that pediatric UC is similar to an extreme form of adult onset UC, with
a major contribution from the HLA. We observed that the effect
of HLA is larger in females when compared to males in pediatric UC. We are intrigued by this discovery because never has
a gender biased genetic risk been seen in UC in either pediatric
onset or adult onset UC. The HLA being the dominant association in pediatric UC onset further fueling our speculation that
antigenic stimulation either infectious or non-infectious as a
precipitating event for such an early onset. The most interesting
findings from this study are (1) 2 classical HLA-DRB1 alleles
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are shared with adult onset UC and, (2) other 2 independent signals are specific to pediatric onset UC. Further studies in pediatric UC with larger sample sizes from more ethnically diverse
cohorts combining microbiome studies should be dedicated to
better dissect the HLA region, and in turn, those findings may
help in individualized medical approaches, pharmacogenomics,
and risk stratification in pediatric UC.

SUPPLEMENTARY DATA
Supplementary data are available at Inflammatory Bowel
Diseases online.
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